Showing 159 articles tagged

Progress and promise in a fast-moving year since the launch of our life-saving strategy

3 Mar 2017

BLOG: It's been 12 months since we launched our ambitious plan to halve prostate cancer deaths in a decade, and we’ve already taken some huge steps towards our goal. Our chief executive, Angela Culhane, reflects on the progress we’ve made and the exciting work still to come.

We're urging the Prime Minister to end the NHS crisis - and we're ready to help

15 Feb 2017

BLOG: Today, Prostate Cancer UK and 67 other charities signed a joint letter to the Prime Minister, urging the government to use the Spring Budget to give the NHS the money it needs to end the current crisis. Our Change Delivery Manager, Martin Abrams, explains why the NHS's whole future is at stake.

Only a third of men currently benefit from 'biggest leap forward in diagnosis for decades'

20 Jan 2017

After today's confirmation that mpMRI scans before a biopsy can radically improve the accuracy of prostate cancer diagnosis, figures reveal that just 32% of eligible men currently have access to the procedure because of a shortage of scanners and qualified staff to use them in the NHS.

How playing the long game and your donations led to mpMRI breakthrough

20 Jan 2017

BLOG: Today's announcement about mpMRI scans before a biopsy is a game-changer for prostate cancer diagnosis. But without Prostate Cancer UK's funding of a pilot project in 2010 thanks to your donations, this ground-breaking research would never have happened, says Dr Ian Le Guillou.

National Prostate Cancer Audit results: most men happy with curative treatment but overtreatment still a problem

14 Dec 2016

The Royal College of Surgeons finds 90 per cent of men who had surgery or radiotherapy to cure their prostate cancer on the English NHS rated their care as very good. But Prostate Cancer UK is concerned that over-treatment of men with low-risk localised disease hasn't declined.

Cabazitaxel decision in Scotland finally ends UK variation in NHS drug access

12 Dec 2016

Today's Scottish green light for the chemotherapy drug means the same key treatments for advanced prostate cancer are now routinely available to eligible men in all the home nations.

Prostate cancer patients ‘abandoned to deal with erection problems alone’

17 Nov 2016

Just 13% of UK's local health commissioners provide adequate care for erectile dysfunction, reveal shocking new figures uncovered by Prostate Cancer UK, leaving thousands of men recovering from prostate cancer treatment struggling with the devastating effects on their health and relationships.

Turning guidelines into lifelines: NICE agrees to early review of treatment protocol for prostate cancer

8 Nov 2016

BLOG: After Prostate Cancer UK bombarded the health authority with substantial evidence and demanded changes, NICE announced they will now undertake an exceptional review of their prostate cancer clinical guidelines. Our CEO, Angela Culhane, explains why it will mean life-saving new diagnosis and treatment should reach thousands of men sooner than expected.

We can have world-class treatment for men with prostate cancer despite the NHS funding crisis

1 Nov 2016

BLOG: While doom-laden reports about chronic underfunding appear daily in the news, the NHS is still committed to transforming cancer treatment in the UK by 2020. So is it all just pie in the sky? Our Policy Manager, Phillip Anderson, doesn't think so, but argues we must get smarter about making our case for investment in prostate cancer if we're going to get the best deal for men.

Academy of Medical Royal Colleges questions use of PSA test

24 Oct 2016

A new report from the medical professionals' body includes the PSA test as one of 40 medical treatments that may be unnecessary for many men. But Prostate Cancer UK makes clear that the test is still the best first step for diagnosis of prostate cancer while we develop a more robust test suitable for a screening programme.